人类免疫健康的统一度量指标
研究整合228例22种单基因免疫疾病患者与42例年龄性别匹配健康对照的转录组、血清蛋白、免疫细胞频率及临床数据,用无监督或有监督机器学习独立识别出可将健康者与单基因病患者区分开的评分,提出定量免疫健康指标(IHM)。在十个独立数据集中,IHM可区分健康与多基因自身免疫及炎症性疾病状态、标记临床健康个体的衰老、追踪免疫与非免疫疾病的疾病活动与治疗反应,并预测不同疫苗的年龄依赖性抗体反应。
要点
- IHM由转录组、血清蛋白、免疫细胞频率及临床数据经机器学习识别,可区分健康者与单基因病患者。
- 在十个独立数据集中,IHM可区分健康与多基因自身免疫及炎症性疾病状态。
- IHM可标记临床健康个体的衰老、追踪疾病活动与治疗反应,并预测年龄依赖性疫苗抗体反应。
核心结论
- 不同疾病状态包括衰老具有共同的系统性免疫后果,偏离健康状态可由IHM定量反映。
- IHM的区分能力超出经典炎症生物标志物C反应蛋白和白细胞介素-6。
- 作者提供用于计算其他数据集IHM的网络平台,可能助力精准医学。
研究设计与样本
- 整合228例22种影响关键免疫通路的单基因疾病患者与42例年龄和性别匹配健康对照的转录组学、血清蛋白、外周免疫细胞频率及临床数据。
- 采用无监督或有监督机器学习独立识别免疫健康评分。
主要发现
- 尽管单基因病变外显率高,个体间多种免疫参数差异往往超过可归因于疾病状态或药物使用的差异。
- 无监督或有监督机器学习独立识别出可区分健康参与者与单基因病患者的评分,提示定量免疫健康指标(IHM)。
- 在十个独立数据集中,IHM区分健康与多基因自身免疫及炎症性疾病状态、标记临床健康个体的衰老、追踪免疫与非免疫疾病的疾病活动与治疗反应,并预测不同疫苗的年龄依赖性抗体反应。
- IHM的区分能力超出经典炎症生物标志物C反应蛋白和白细胞介素-6。
关键数值与推荐
- IHM在十个独立数据集中展现区分能力,超出C反应蛋白和白细胞介素-6。
临床怎么用
- 作者提供用于计算其他数据集IHM的网络平台,可能助力精准医学。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Immunological health has been challenging to characterize but could be defined as the absence of immune pathology. While shared features of some immune diseases and the concept of immunologic resilience based on age-independent adaptation to antigenic stimulation have been developed, general metrics of immune health and its utility for assessing clinically healthy individuals remain ill defined. Here we integrated transcriptomics, serum protein, peripheral immune cell frequency and clinical data from 228 patients with 22 monogenic conditions impacting key immunological pathways together with 42 age- and sex-matched healthy controls. Despite the high penetrance of monogenic lesions, differences between individuals in diverse immune parameters tended to dominate over those attributable to disease conditions or medication use. Unsupervised or supervised machine learning independently identified a score that distinguished healthy participants from patients with monogenic diseases, thus suggesting a quantitative immune health metric (IHM). In ten independent datasets, the IHM discriminated healthy from polygenic autoimmune and inflammatory disease states, marked aging in clinically healthy individuals, tracked disease activities and treatment responses in both immunological and nonimmunological diseases, and predicted age-dependent antibody responses to immunizations with different vaccines. This discriminatory power goes beyond that of the classical inflammatory biomarkers C-reactive protein and interleukin-6. Thus, deviations from health in diverse conditions, including aging, have shared systemic immune consequences, and we provide a web platform for calculating the IHM for other datasets, which could empower precision medicine.
引用
- Sparks R, Rachmaninoff N, Lau WW, et al. A unified metric of human immune health. Nat Med. 2024. PMID: 38961223. doi:10.1038/s41591-024-03092-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。